|
May 9
|
Celldex Therapeutics, Inc. (CLDX): Among the Best Cancer Stocks to Invest in for Long-Term Gain
|
|
May 8
|
Celldex Therapeutics (CLDX) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 8
|
Celldex: Q1 Earnings Snapshot
|
|
May 8
|
Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update
|
|
May 5
|
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
|